Conventional and Alternative Treatment Approaches for Infection

Overview

Journal Int J Health Sci (Qassim)

Specialty General Medicine

Date 2017 Mar 16

PMID 28293151

Citations 4

Authors

Khalid M Aljarallah

Affiliations

Soon will be listed here.

Abstract

-associated disease continues to be one of the leading health concerns worldwide. is considered as a causative agent of nosocomial diarrhea that causes serious infection, which may result in death. The incidences of infection (CDI) in developed countries have become increasingly high which may be attributed to the emergence of newer epidemic strains, extensive use of antibiotics, and limited alternative therapies. The available treatment options against CDI are expensive and promote resistance. Therefore, there is urgent need for new approaches to meet these challenges. This review discusses the current understanding of CDI, the existing clinical treatment strategies and future potential options as antidifficile agents based on the available published works.

Citing Articles

Clostridioides difficile Infection: A Clinical Review of Pathogenesis, Clinical Considerations, and Treatment Strategies.

Sinnathamby E, Mason J, Flanagan C, Pearl N, Burroughs C, De Witt A Cureus. 2024; 15(12):e51167.

PMID: 38283489 PMC: 10811429. DOI: 10.7759/cureus.51167.

Beneficial Effect of Paeonol on Antibiotic-Associated Inflammatory Response in Mice with Diarrhea.

Kang B, Park D, Lee M, Jeon C, Kang K, Choi Y Biomolecules. 2022; 12(11).

PMID: 36358984 PMC: 9687136. DOI: 10.3390/biom12111634.

Black Seed Oil, Bentonite Clay, and Probiotics: A Comprehensive Holistic Cure for Infection in a 2-Year-Old Female Child.

Littman E, Winningham N, Carson T, Hidalgo I Case Rep Infect Dis. 2022; 2022:2002488.

PMID: 35677311 PMC: 9168092. DOI: 10.1155/2022/2002488.

An Efficient One-Pot Catalyzed Synthesis of 2,4-Disubstituted 5-Nitroimidazoles Displaying Antiparasitic and Antibacterial Activities.

Mathias F, Kabri Y, Okdah L, di Giorgio C, Rolain J, Spitz C Molecules. 2017; 22(8).

PMID: 28771219 PMC: 6152245. DOI: 10.3390/molecules22081278.

References

Dubberke E, Han Z, Bobo L, Hink T, Lawrence B, Copper S . Impact of clinical symptoms on interpretation of diagnostic assays for Clostridium difficile infections. J Clin Microbiol. 2011; 49(8):2887-93. PMC: 3147743. DOI: 10.1128/JCM.00891-11. View

Gardiner D, Rosenberg T, Zaharatos J, Franco D, Ho D . A DNA vaccine targeting the receptor-binding domain of Clostridium difficile toxin A. Vaccine. 2009; 27(27):3598-604. PMC: 2709243. DOI: 10.1016/j.vaccine.2009.03.058. View

Mullane K, Gorbach S . Fidaxomicin: first-in-class macrocyclic antibiotic. Expert Rev Anti Infect Ther. 2011; 9(7):767-77. DOI: 10.1586/eri.11.53. View

Furuya-Kanamori L, Marquess J, Yakob L, Riley T, Paterson D, Foster N . Asymptomatic Clostridium difficile colonization: epidemiology and clinical implications. BMC Infect Dis. 2015; 15:516. PMC: 4647607. DOI: 10.1186/s12879-015-1258-4. View

Rodrigues F, Costa J, Coutinho H . Synergy effects of the antibiotics gentamicin and the essential oil of Croton zehntneri. Phytomedicine. 2009; 16(11):1052-5. DOI: 10.1016/j.phymed.2009.04.004. View

Surawicz C, Brandt L, Binion D, Ananthakrishnan A, Curry S, Gilligan P . Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol. 2013; 108(4):478-98. DOI: 10.1038/ajg.2013.4. View

Ammam F, Meziane-Cherif D, Mengin-Lecreulx D, Blanot D, Patin D, Boneca I . The functional vanGCd cluster of Clostridium difficile does not confer vancomycin resistance. Mol Microbiol. 2013; 89(4):612-25. DOI: 10.1111/mmi.12299. View

Perkins H, Nieto M . The chemical basis for the action of the vancomycin group of antibiotics. Ann N Y Acad Sci. 1974; 235(0):348-63. DOI: 10.1111/j.1749-6632.1974.tb43276.x. View

Crobach M, Dekkers O, Wilcox M, Kuijper E . European Society of Clinical Microbiology and Infectious Diseases (ESCMID): data review and recommendations for diagnosing Clostridium difficile-infection (CDI). Clin Microbiol Infect. 2009; 15(12):1053-66. DOI: 10.1111/j.1469-0691.2009.03098.x. View

10.

Lachowicz D, Pituch H, Obuch-Woszczatynski P . Antimicrobial susceptibility patterns of Clostridium difficile strains belonging to different polymerase chain reaction ribotypes isolated in Poland in 2012. Anaerobe. 2014; 31:37-41. DOI: 10.1016/j.anaerobe.2014.09.004. View

11.

Wren B, Mullany P, Clayton C, TABAQCHALI S . Nucleotide sequence of a chloramphenicol acetyl transferase gene from Clostridium difficile. Nucleic Acids Res. 1989; 17(12):4877. PMC: 318042. DOI: 10.1093/nar/17.12.4877. View

12.

Brantner A, Grein E . Antibacterial activity of plant extracts used externally in traditional medicine. J Ethnopharmacol. 1994; 44(1):35-40. DOI: 10.1016/0378-8741(94)90096-5. View

13.

Rineh A, Kelso M, Vatansever F, Tegos G, Hamblin M . Clostridium difficile infection: molecular pathogenesis and novel therapeutics. Expert Rev Anti Infect Ther. 2014; 12(1):131-50. PMC: 4306399. DOI: 10.1586/14787210.2014.866515. View

14.

Jeevan Ram A, Bhakshu L, Venkata Raju R . In vitro antimicrobial activity of certain medicinal plants from eastern Ghats, India, used for skin diseases. J Ethnopharmacol. 2004; 90(2-3):353-7. DOI: 10.1016/j.jep.2003.10.013. View

15.

Mullany P, Wilks M, Lamb I, Clayton C, Wren B, TABAQCHALI S . Genetic analysis of a tetracycline resistance element from Clostridium difficile and its conjugal transfer to and from Bacillus subtilis. J Gen Microbiol. 1990; 136(7):1343-9. DOI: 10.1099/00221287-136-7-1343. View

16.

Corver J, Bakker D, Brouwer M, Harmanus C, Hensgens M, Roberts A . Analysis of a Clostridium difficile PCR ribotype 078 100 kilobase island reveals the presence of a novel transposon, Tn6164. BMC Microbiol. 2012; 12:130. PMC: 3485107. DOI: 10.1186/1471-2180-12-130. View

17.

Fry P, Thakur S, Abley M, Gebreyes W . Antimicrobial resistance, toxinotype, and genotypic profiling of Clostridium difficile isolates of swine origin. J Clin Microbiol. 2012; 50(7):2366-72. PMC: 3405606. DOI: 10.1128/JCM.06581-11. View

18.

Clardy J, Walsh C . Lessons from natural molecules. Nature. 2004; 432(7019):829-37. DOI: 10.1038/nature03194. View

19.

Huang J, Jiang Z, Garey K, Lasco T, DuPont H . Use of rifamycin drugs and development of infection by rifamycin-resistant strains of Clostridium difficile. Antimicrob Agents Chemother. 2013; 57(6):2690-3. PMC: 3716149. DOI: 10.1128/AAC.00548-13. View

20.

Gough E, Shaikh H, Manges A . Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis. 2011; 53(10):994-1002. DOI: 10.1093/cid/cir632. View